Nova News

Jan
2021

HSC MEDICAL CENTRE TO IMPLEMENT VESALIUS AS PART OF ITS EXPANSION PLAN

Jan 2021 – HSC Medical Center (HSC), conveniently located in the heart of Kuala Lumpur, within walking distance of the iconic Petronas Twin Towers was officially opened by the Minister of Health on 18 February 2003. It is an award-winning medical centre and a one-stop advanced health screening hub for local and international visitors and patients. Apart from offering comprehensive health…

Read more

Jan
2021

SELENA+ RECEIVES REGULATORY APPROVAL IN INDONESIA

Jan 2021 – In Indonesia, it is estimated that nearly 16 million adults to be living with type 2 diabetes. More worringly, experts estimate more than half of diabetes cases in Indonesia remain undiagnosed, especially among young people. Every is at risk of going blind. Around a third of diabetics develop some form of eye health complication and is at…

Read more

Dec
2020

BUILDING & CONSTRUCTION AUTHORITY, SINGAPORE AWARD BIM MODEL CHECKER PROJECT TO NOVA

Dec 2020 – Singapore’s Building and Construction Authority (BCA) has awarded to novaCITYNETS, a subsidiary of Nova MSC the project to develop a BIM Model Checking System. The BIM Model Checking System is to facilitate automatic multi-disciplinary building code checking on open format IFC BIM models. The System is intended for pre-checking of designs to reduce design errors, omissions and…

Read more

Nov
2020

EYRIS PARTNERS TOPCON HEALTHCARE SOLUTIONS TO ROLL OUT SELENA+ IN HARMONY RS FOR 18 ASIAN COUNTRIES

Singapore (9 Nov, 2020) – Topcon Healthcare Solutions Asia Pacific, the leading Japanese ophthalmic solution provider, has inked an agreement with Singapore based EyRIS Private Limited to bring EyRIS SELENA+ to Harmony’s users in 18 countries in South and South East Asia. SELENA+ is a deep learning system (DLS) that can detect 3 eye diseases – diabetic retinopathy, glaucoma suspect…

Read more

Oct
2020

SELENA+ RECEIVES REGULATORY APPROVAL IN BRAZIL

Oct 2020 – SELENA+ received regulatory approval for commercialisation from ANVISA (Agência Nacional de Vigilância Sanitária) or the National Health Surveillance Agency. ANVISA is the regulatory agency that is responsible for the approval and supervision of food, cosmetics, tobacco, pharmaceuticals, health services, and medical devices in Brazil. Brazil is one of the 20 countries of the International Diabetes Federation (IDF)…

Read more

Oct
2020

EYRIS NAMED IN “50 INNOVATIVE COMPANIES TO WATCH 2020” LIST

Oct 2020 – EyRIS was named on the list “50 INNOVATIVE COMPANIES TO WATCH 2020” compiled by The Silicon Review. The list recognizes companies that have come up with transformative innovations that deliver a fundamental shift to a new way of doing things. EyRIS stands out amongst AI companies in the healthcare sector for developing SELENA+, an AI Deep Learning…

Read more

Oct
2020

PROF WONG TIEN YIN, EYRIS CO-FOUNDER ELECTED INTO US NATIONAL ACADEMY OF MEDICINE

Oct 2020 – Every year, the US National Academy of Medicine welcomes 90 regular members and 10 international members during its annual meeting. Election to the Academy is considered one of the highest honours in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service. It fills us with pride to…

Read more

Oct
2020

FIRST EYE CENTRE IN MALAYSIA TO UTILISE ARTIFICIAL INTELLIGENCE (AI) FOR RETINAL DISEASE DETECTION

Oct 2020 –  According to the International Diabetes Federation, there are just below 1.8 million undiagnosed diabetics in Malaysia. It is estimated that 17 out of every 100 in Malaysia is suffering from this chronic yet silent condition. One of the most common complication from diabetes is diabetic retinopathy which is asymptomatic during early stages but can lead to blindness…

Read more

Oct
2020

EYRIS WELCOMES DR GAVIN TAN TO OUR ADVISORY BOARD

Oct 2020 – We are pleased to welcome Assoc Prof Gavin Tan onto our Advisory Board. Gavin is a Senior Consultant at the Retina Centre in Singapore National Eye Centre, specialising in General Ophthalmology and Cataract Surgery, and a subspecialist in vitreo-retinal surgery. In addition, he is actively involved with academic research and leads multiple Clinical Trials at the Singapore…

Read more

Oct
2020

NEW ADVENTURE FOR EYRIS IN VIETNAM

14 Oct 2020 – Vietnam Global Innovation (VGI), powered by Quest Ventures, concluded its extensive three-month program last week. Focused on providing Singaporean start-ups an accelerated entry into Vietnam, VGI has pushed through the challenges brought on by COVID-19 to provide its participants with knowledge and insights for their next stage of growth. EyRIS is one of the start-ups that…

Read more

Sep
2020

EYRIS AWARDED 5-YEAR CONTRACT TO DEPLOY SELENA+

Sep 2020 – EyRIS was awarded a 5-year contract for the deployment of SELENA+, an deep learning system to detect diabetic retinopathy, glaucoma and age-related macular degeneration in the Singapore Integrated Diabetic Retinopathy Program (SiDRP). This award is not only a milestone for EyRIS but also a world first in showcasing real world adoption of an artificial intelligence medical device…

Read more

Sep
2020

EYRIS CO-FOUNDERS RECOGNISED FOR CONTRIBUTION IN TECH SECTOR

Sep 2020 – We extend our heartiest congratulations to both co-founders of EyRIS, Profs Wynne Hsu and Lee Mong Li for making it onto the inaugural Singapore 100 Women in Tech (SG100WIT) List. The SGWIT100 2020 recognises the contributions of women in the tech sector and nominees are celebrated for their ability to influence, inspire and impact on community and…

Read more